Dyadic International Inc (DYAI)
1.480
+0.01
(+0.69%)
USD |
NASDAQ |
May 02, 16:00
1.44
-0.04
(-2.71%)
Pre-Market: 20:00
Dyadic International Gross Profit (Quarterly): 0.3364M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.3364M |
September 30, 2023 | 0.2912M |
June 30, 2023 | 0.0442M |
March 31, 2023 | 0.2511M |
December 31, 2022 | 0.0392M |
September 30, 2022 | 0.2767M |
June 30, 2022 | 0.2474M |
March 31, 2022 | 0.2437M |
December 31, 2021 | -0.0183M |
September 30, 2021 | 0.3004M |
June 30, 2021 | 0.1076M |
March 31, 2021 | 0.0698M |
December 31, 2020 | 0.0903M |
September 30, 2020 | 0.1494M |
June 30, 2020 | -0.10M |
March 31, 2020 | 0.0372M |
December 31, 2019 | 0.0084M |
September 30, 2019 | 0.0697M |
June 30, 2019 | 0.0686M |
March 31, 2019 | 0.0746M |
December 31, 2018 | 0.1789M |
September 30, 2018 | 0.0196M |
June 30, 2018 | 0.0322M |
March 31, 2018 | 0.0375M |
December 31, 2017 | 0.0187M |
Date | Value |
---|---|
September 30, 2017 | 0.052M |
June 30, 2017 | 0.0076M |
March 31, 2017 | -0.00 |
December 31, 2016 | 0.0737M |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.0013M |
March 31, 2016 | 0.0017M |
December 31, 2015 | -0.0019M |
September 30, 2015 | 0.1785M |
June 30, 2015 | 0.006M |
March 31, 2015 | 0.0071M |
December 31, 2014 | -0.0559M |
September 30, 2014 | -0.0029M |
March 31, 2014 | 1.006M |
December 31, 2013 | 1.055M |
September 30, 2013 | 0.6913M |
June 30, 2013 | 5.144M |
March 31, 2013 | 0.5204M |
September 30, 2012 | 0.6138M |
June 30, 2012 | 5.984M |
March 31, 2012 | 0.7568M |
December 31, 2006 | 0.765M |
September 30, 2006 | 1.312M |
June 30, 2006 | 1.076M |
March 31, 2006 | 0.8854M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
-0.10M
Minimum
Jun 2020
0.3364M
Maximum
Dec 2023
0.1323M
Average
0.0903M
Median
Dec 2020
Gross Profit (Quarterly) Benchmarks
AIM ImmunoTech Inc | 0.053M |
Perspective Therapeutics Inc | -- |
Protalix BioTherapeutics Inc | 1.63M |
Electromed Inc | 10.54M |
Armata Pharmaceuticals Inc | -- |